Prognostic implications of coronary calcification in patients with obstructive coronary artery disease treated by percutaneous coronary intervention: A patient-level pooled analysis of 7 contemporary stent trials

Heart

Volumn 100, Issue 15, 2014, Pages 1158-1164

  Bourantas, Christos V ^a   Zhang, Yao Jun ^a   Garg, Scot ^b   Iqbal, Javaid ^a   Valgimigli, Marco ^a   Windecker, Stephan ^c   Mohr, Friedrich W ^d   Silber, Sigmund ^e   De Vries, Ton ^f   Onuma, Yoshinobu ^a   Garcia Garcia, Hector M ^a   Morel, Marie Angele ^f   Serruys, Patrick W ^a,g  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b EAST LANCASHIRE HOSPITALS NHS TRUST   (United Kingdom)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^e Heart Center at the Isar   (Germany)

^f CARDIALYSIS   (Netherlands)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; PACLITAXEL; RAPAMYCIN; UMIROLIMUS; ZOTAROLIMUS;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; DEATH; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NETHERLANDS; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STENT THROMBOSIS; TREATMENT OUTCOME;

AGED; CALCINOSIS; CAUSE OF DEATH; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY OCCLUSION; CORONARY VESSELS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STENTS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84904038548     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-305180     Document Type: Article

References (31)

1. Savage MP, Goldberg S, Hirshfeld JW, et al. Clinical and angiographic determinants of primary coronary angioplasty success M-HEART Investigators. J Am Coll Cardiol 1991;17:22-8.
2. Moussa I, Di Mario C, Moses J, et al. Coronary stenting after rotational atherectomy in calcified and complex lesions angiographic and clinical follow-up results. Circulation 1997;96:128-36. (Pubitemid 27298414)
3. Moussa I, Ellis SG, Jones M, et al. Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study). Am J Cardiol 2005;96:1242-7. (Pubitemid 41505401)
4. Onuma Y, Tanimoto S, Ruygrok P, et al. Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: Two-year angiographic and three-year clinical results from the SPIRIT II study. Catheter Cardiovasc Interv 2010;76:634-42.
5. Costa JR Jr, Sousa A, Moreira AC, et al. Incidence and predictors of very late (>or=4 years) major cardiac adverse events in the DESIRE (Drug-Eluting Stents in the Real World)-Late registry. JACC Cardiovasc Interv 2010;3:12-18.
6. Lasala JM, Cox DA, Dobies D, et al. Drug-eluting stent thrombosis in routine clinical practice: Two-year outcomes and predictors from the TAXUS ARRIVE registries. Circ Cardiovasc Interv 2009;2:285-93.
7. Kawaguchi R, Tsurugaya H, Hoshizaki H, et al. Impact of lesion calcification on clinical and angiographic outcome after sirolimus-eluting stent implantation in real-world patients. Cardiovasc Revasc Med 2008;9:2-8.
8. Fujimoto H, Nakamura M, Yokoi H. Impact of calcification on the long- Term outcomes of sirolimus-eluting stent implantation: subanalysis of the Cypher Post-Marketing Surveillance Registry. Circ J 2012;76:57-64.
9. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary- Artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-72.
10. Serruys PW, Silber S, Garg S, et al. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med 2010;363:136-46.
11. Windecker S, Remondino A, Eberli FR, et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 2005;353:653-62. (Pubitemid 41175673)
12. Windecker S, Serruys PW, Wandel S, et al. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): A randomised non-inferiority trial. Lancet 2008;372:1163-73.
13. Serruys PW, Ong AT, Morice MC, et al. Arterial Revascularisation Therapies Study Part II-Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. EuroIntervention 2005;1:147-56.
14. Valgimigli M, Percoco G, Malagutti P, et al. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: A randomized trial. JAMA 2005;293:2109-17. (Pubitemid 40617063)
15. Valgimigli M, Campo G, Percoco G, et al. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: The MULTISTRATEGY randomized trial. JAMA 2008;299:1788-99. (Pubitemid 351549970)
16. Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: An angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005;1:219-27.
17. Mintz GS, Popma JJ, Pichard AD, et al. Patterns of calcification in coronary artery disease a statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions. Circulation 1995;91:1959-65.
18. Garg S, Sarno G, Girasis C, et al. A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6, 508 patients enrolled in contemporary coronary stent trials. JACC Cardiovasc Interv 2011;4:645-53.
19. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007;115:2344-51. (Pubitemid 46685903)
20. Folsom AR, Kronmal RA, Detrano RC, et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: The Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 2008;168:1333-9. (Pubitemid 351930841)
21. Shemesh J, Morag-Koren N, Goldbourt U, et al. Coronary calcium by spiral computed tomography predicts cardiovascular events in high-risk hypertensive patients. J Hypertens 2004;22:605-10. (Pubitemid 38368495)
22. Leaman DM, Brower RW, Meester GT, et al. Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function. Circulation 1981;63:285-99.
23. Farooq V, Vergouwe Y, Raber L, et al. Combined anatomical and clinical factors for the long- Term risk stratification of patients undergoing percutaneous coronary intervention: The Logistic Clinical SYNTAX score. Eur Heart J 2012;33:3098-104.
24. Garg S, Sarno G, Garcia-Garcia HM, et al. A new tool for the risk stratification of patients with complex coronary artery disease: The Clinical SYNTAX Score. Circ Cardiovasc Interv 2010;3:317-26.
25. Farooq V, Serruys PW, Zhang Y, et al. Short- Term and long- Term clinical impact of stent thrombosis and graft occlusion in the SYNTAX trial at 5 years: Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery trial. J Am Coll Cardiol 2013;62:2360-9.
26. Farooq V, Serruys PW, Bourantas CV, et al. Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score. Circulation 2013;128:141-51.
27. Basavarajaiah S, Naganuma T, Latib A, et al. Can bioabsorbable scaffolds be used in calcified lesions? Catheter Cardiovasc Interv 2013;16.
28. Parikh K, Chandra P, Choksi N, et al. Safety and feasibility of orbital atherectomy for the treatment of calcified coronary lesions: The ORBIT I trial. Catheter Cardiovasc Interv 2013;81:1134-9.
29. Tuzcu EM, Berkalp B, De Franco AC, et al. The dilemma of diagnosing coronary calcification: Angiography versus intravascular ultrasound. J Am Coll Cardiol 1996;27:832-8. (Pubitemid 26104864)
30. Herrman JP, Azar A, Umans VA, et al. Inter- And intra-observer variability in the qualitative categorization of coronary angiograms. Int J Card Imaging 1996;12:21-30. (Pubitemid 26098867)
31. Genereux P, Palmerini T, Caixeta A, et al. SYNTAX score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements. Circ Cardiovasc Interv 2011;4:553-61.